These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary malignant liver tumors: association with oral contraceptives. Vana J; Murphy GP N Y State J Med; 1979 Mar; 79(3):321-5. PubMed ID: 218150 [No Abstract] [Full Text] [Related]
7. Cancer of the liver and the use of oral contraceptives. Forman D; Vincent TJ; Doll R Br Med J (Clin Res Ed); 1986 May; 292(6532):1357-61. PubMed ID: 3011186 [TBL] [Abstract][Full Text] [Related]
12. Oral-contraceptive-induced benign liver tumors--the magnitude of the problem. Jick H; Herman R JAMA; 1978 Sep; 240(9):828-9. PubMed ID: 671723 [No Abstract] [Full Text] [Related]
13. Hepatic adenoma following short period of oral contraceptive use. Naduka CC J Am Board Fam Pract; 1999; 12(4):337-9. PubMed ID: 10477198 [No Abstract] [Full Text] [Related]
14. Hepatic adenoma: a possible complication of oral contraceptive therapy. Hilliard JL; Graham DY; Spjut HJ South Med J; 1976 Jun; 69(6):683-7. PubMed ID: 935896 [TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive use and liver cancer. Palmer JR; Rosenberg L; Kaufman DW; Warshauer ME; Stolley P; Shapiro S Am J Epidemiol; 1989 Nov; 130(5):878-82. PubMed ID: 2554724 [TBL] [Abstract][Full Text] [Related]
16. Transplantable malignant cholangiocarcinoma from hamster liver. Glaser OG; Newberne PM; Gabliks J; Friedman L Arch Environ Health; 1971 Aug; 23(2):137-41. PubMed ID: 4326835 [No Abstract] [Full Text] [Related]